Clinical Trials Directory

Trials / Completed

CompletedNCT01258426

Human Selenoprotein P Concentration With Glucose Tolerance Status

Status
Completed
Phase
Study type
Observational
Enrollment
Sponsor
Korea University · Academic / Other
Sex
All
Age
20 Years – 80 Years
Healthy volunteers
Accepted

Summary

Recently, seslenium(Se) has known as important regulator in metabolic status, lipid profile, atherosclerosis progression. SEPP1(selenoprotein P1)is a secreted protein from mainly liver. This protein is used as an index of selenium nutritional status. The association between the concentration of SEPP1(selenoprotein P1) in normal glucose tolerance,impaired glucose tolerance, type 2 diabetes is still a matter of debate. This cross sectional study will evaluate whether glucose status is matter in SEPP1 level.

Conditions

Timeline

First posted
2010-12-13
Last updated
2010-12-13

Source: ClinicalTrials.gov record NCT01258426. Inclusion in this directory is not an endorsement.